Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jansen

Showing results (1141-1150 of 1,668) with videos related to

Pageof 167
Sort By:
Inflammatory Bowel Diseases|September 14, 2013
Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: a retrospective study comparing the performance of the updated AGA and BSG guidelinesErik Mooiweer, Andrea E van der Meulen, Adriaan A van Bodegraven, et al.
United European Gastroenterology Journal|June 2, 2021
Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapyPepijn W A Thomas, Tessa E H Römkens, Rachel L West, et al.
Endoscopy|June 1, 2026
Aberrant p53 expression, a stronger risk factor for neoplastic progression in Barrett's esophagus than confirmed low grade dysplasia: a large multicenter prospective cohort studyPauline A Zellenrath, Nanda Provoost, Jeliena C M Jansen, et al.
Annals of Surgical Oncology|August 29, 2014
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort studyJurriën Stiekema, Anouk K Trip, Edwin P M Jansen, et al.
Inflammatory Bowel Diseases|February 8, 2022
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective StudyPepijn W A Thomas, Nathan den Broeder, Monique Derikx, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 2, 2020
First in Human Clinical Feasibility Study of Endovascular Navigation with Fiber Optic RealShape (FORS) TechnologyJoost A van Herwaarden, Marloes M Jansen, Evert-Jan P A Vonken, et al.
Experimental Dermatology|June 8, 2020
Know your enemy: Unexpected, pervasive and persistent viral and bacterial contamination of primary cell culturesHanna Niehues, Patrick A M Jansen, Diana Rodijk-Olthuis, et al.
Biomaterials|July 27, 2013
Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in ratsWim H De Jong, Leo T M Van Der Ven, Annemarie Sleijffers, et al.
International Archives of Allergy and Immunology|January 1, 1994
Variability of IgE-dependent histamine-releasing activity in supernatants of human mononuclear cellsS G Pasmans, A M Witteman, M Aalbers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 20, 2020
Quantitative change of perfusion in gastric tube reconstruction by sidestream dark field microscopy (SDF) after esophagectomy, a prospective in-vivo cohort studySanne M Jansen, Daniel M de Bruin, Mark I van Berge Henegouwen, et al.
Pageof 167

Showing results (1141-1150 of 1,668) with videos related to

Sort By:
Pageof 167
Inflammatory Bowel Diseases|September 14, 2013
Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: a retrospective study comparing the performance of the updated AGA and BSG guidelinesErik Mooiweer, Andrea E van der Meulen, Adriaan A van Bodegraven, et al.
United European Gastroenterology Journal|June 2, 2021
Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapyPepijn W A Thomas, Tessa E H Römkens, Rachel L West, et al.
Endoscopy|June 1, 2026
Aberrant p53 expression, a stronger risk factor for neoplastic progression in Barrett's esophagus than confirmed low grade dysplasia: a large multicenter prospective cohort studyPauline A Zellenrath, Nanda Provoost, Jeliena C M Jansen, et al.
Annals of Surgical Oncology|August 29, 2014
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort studyJurriën Stiekema, Anouk K Trip, Edwin P M Jansen, et al.
Inflammatory Bowel Diseases|February 8, 2022
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective StudyPepijn W A Thomas, Nathan den Broeder, Monique Derikx, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 2, 2020
First in Human Clinical Feasibility Study of Endovascular Navigation with Fiber Optic RealShape (FORS) TechnologyJoost A van Herwaarden, Marloes M Jansen, Evert-Jan P A Vonken, et al.
Experimental Dermatology|June 8, 2020
Know your enemy: Unexpected, pervasive and persistent viral and bacterial contamination of primary cell culturesHanna Niehues, Patrick A M Jansen, Diana Rodijk-Olthuis, et al.
Biomaterials|July 27, 2013
Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in ratsWim H De Jong, Leo T M Van Der Ven, Annemarie Sleijffers, et al.
International Archives of Allergy and Immunology|January 1, 1994
Variability of IgE-dependent histamine-releasing activity in supernatants of human mononuclear cellsS G Pasmans, A M Witteman, M Aalbers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 20, 2020
Quantitative change of perfusion in gastric tube reconstruction by sidestream dark field microscopy (SDF) after esophagectomy, a prospective in-vivo cohort studySanne M Jansen, Daniel M de Bruin, Mark I van Berge Henegouwen, et al.
Pageof 167